CI Investments Inc
FATE icon

CI Investments Inc’s Fate Therapeutics FATE Stock Holding History

CI Investments Inc’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,043
Closed -$17K – 1328
2023
Q1 		$17K Sell
3,043
-39
-1% -$235 ﹤0.01% 1068
2022
Q4 		$31K Buy
3,082
+2,482
+414% +$46.6K ﹤0.01% 1023
2022
Q3 		$13K Sell
600
-44
-7% -$1.27K ﹤0.01% 1102
2022
Q2 		$16K Buy
644
+180
+39% +$4.97K ﹤0.01% 997
2022
Q1 		$18K Buy
464
+460
+11,500% +$17.8K ﹤0.01% 1058
2021
Q4 		$0 Hold
4
– – ﹤0.01% 1323
2021
Q3 		$0 Buy
+4
New +$314 ﹤0.01% 1297

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

CI Investments Inc's FATE Position: Q2 2023 in Review

CI Investments Inc sold out of Fate Therapeutics (FATE) in Q2 2023, closing a stake of 3,043 shares — an estimated $17K sold.

CI Investments Inc first reported a position in FATE in Q3 2021 and held it in 7 quarters. The position peaked at $31K in Q4 2022. 188 funds tracked by Wall St. Rank hold FATE as of Q2 2023.

  • CI Investments Inc reported no remaining Fate Therapeutics position as of Q2 2023 after selling out during the quarter.
  • CI Investments Inc sold 3,043 Fate Therapeutics shares in Q2 2023, an estimated $17K.
  • CI Investments Inc first reported a position in Fate Therapeutics in Q3 2021 and held it in 7 quarters.
  • CI Investments Inc's Fate Therapeutics position peaked at $31K in Q4 2022.
  • 188 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2023.

Based on CI Investments Inc's 13F filing for Q2 2023, filed 11 Aug 2023.